India's Krsnaa Diagnostics rises after Systematix starts coverage with 'buy'

Krsnaa Diagnostics

12/06/2024 09:01

** Shares of Krsnaa Diagnostics  KRSN.NS  rise as much as
4.8% to 627.35 rupees, last up 4.1%
    ** Systematix Institutional Equities initiates coverage of
pathology and radiology diagnostics services provider with "buy"
rating and PT at 841 rupees
    ** The PT represents a 40.5% premium to stock's last close
    ** Over the last 5 years, KRSN clocked 34% and 25% CAGR in
revenue and net earnings, respectively - Systematix 
    ** Brokerage estimates 30% and 47% CAGR in KRSN's revenue
and net earnings, respectively, over FY24-FY26, led by
utilization of its recently set up diagnostic centers and
opening of new centers
    ** KRSN's revenue is split 57:43 between radiology and
pathology, and we expect the mix to slightly lean in favour of
radiology in future - Systematix  
    

 (Reporting by Ashish Chandra in Bengaluru)
 ((ashish.chandra@thomsonreuters.com (+91 7982114624))